Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $1079.28
130 weeks after treatment all four patients who took part in Living Cell Technologies Limited’s Phase I/IIa clinical study of NTCELL® for...
Living Cell Technologies Limited has completed treatment of all six patients in group 1 of the Phase IIb clinical trial of NTCELL® for...
As advised in our 7 June announcement of the trial results, Dr Barry Snow is presenting 81 week+ data on the safely and clinical effects of...
81 weeks after treatment all four patients who took part in Living Cell Technologies Limited’s Phase I/IIa clinical study of NTCELL® for...
Living Cell Technologies has received approval from the Auckland Hospital Research Review Committee for the Phase IIb clinical trial of...
Living Cell Technologies Limited has completed the placement of 54,607,546 shares at $0.05063 to wholesale investors resident in New...
Living Cell Technologies (ASX: LCT) (OTCQX: LVCLY) has received approval from the Northern A Health and Disability Ethics Committee for the...
Over a year after treatment all four patients who took part in Living Cell Technologies Limited’s Phase I/IIa clinical study of NTCELL® for...
Living Cell Technologies Advancing Regenerative Cell Therapy into Larger Phase IIb Study to Evaluate Its Potential as a Disease-modifying...
LCT and Otsuka of Japan Share Common DIABECELL(R) Vision * Otsuka Pharmaceutical Factory, Inc invests AUD $3 million for 8.2% interest in LCT...
Living Cell Technologies Limited (ASX:LCT) (OTCQX:LVCLY), a global company pioneering the development of a cell implant to...
Living Cell Technologies Limited (ASX:LCT)(OTCQX:LVCLY), a global company pioneering the development of a cell implant to treat...
Living Cell Technologies Limited (ASX:LCT) (OTCQX:LVCLY), a global company pioneering the development of a cell implant to treat...
SYDNEY and AUCKLAND, New Zealand, June 24 /PRNewswire/ -- Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today announced that the New...
Living Cell Technologies Limited (ASX:LCT; OTCQX: LVCLY) today announced that the Company has commenced a research agreement with...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.